Abstract:BACKGROUND: Abnormal lipid metabolism has been reported in patients with idiopathic pulmonary arterial hypertension (IPAH); however, the prognostic value of plasma free fatty acids (FFAs) for these patients is unclear. The present study aimed to determine whether FFA can play a role in predicting the survival of patients with IPAH.METHODS: A total of 69 blood samples from patients with IPAH were subjected to liquid chromatography-mass spectrometry (LC-MS). According to the classification criteria for pulmonary hypertension in the European Society of Cardiology (ESC) guidelines, patients were divided into low-risk, intermediate-risk, and high-risk groups. The FFA expression levels of patients in the three groups were compared, and the indicators with significant differences were selected. Cox regression analysis was performed to examine the associations between survival and different factors. Receiver operator characteristic (ROC) curves were used to assess the predictive effect of plasma lipids in assessing patients' risk of morbidity, including area under the curve (AUC), sensitivity, specificity and the best cutoff value. Kaplan-Meier curves were used to predict survival.RESULTS: A total of 24 FFA molecules were detected in the patients with IPAH. Among them, FFA (20:4), FFA (20:5), FFA (22:5), FFA (22:6), FFA (24:0) and FFA (30:4) showed significant differences between the low-risk and the intermediate-risk or high-risk patients with IPAH. These six FFAs were significantly correlated with hemodynamic parameters. FFA (22:6), named docosahexaenoic acid (DHA), displayed significant negative correlations with World Health Organization functional classification (WHO FC), mean right atrial pressure (mRAP), and pulmonary vascular resistance (PVR), and significant positive correlations with 6-minute walking distance (6MWD) and cardiac index (CI). Cox regression analyses demonstrated that total bilirubin (TBIL) and DHA were independent risk factors for survival of IPAH. Receiver operating characteristic curve analysis revealed that DHA had a cut-off value of 77.55, which had a sensitivity of 96.7% and a specificity of 62.5% for predicting survival. Kaplan-Meier curve analysis showed that a lower level of DHA predicted a poor outcome in patients with IPAH.CONCLUSIONS: Our study suggested that FFA levels were correlated with disease severity. Lower levels of DHA predict poor survival in patients with IPAH.

E0597 Serum HDL-C Levels Correlated with the Haemodynamic and Severity in Patients with Idiopathic Pulmonary Arterial Hypertension

Serum High-Density Lipoprotein Cholesterol is Significantly Associated with the Presence and Severity of Pulmonary Arterial Hypertension: A Retrospective Cross-Sectional Study.

Study Of The Correlation Between Blood Lipid Levels And The Severity Of Coronary Atherosclerosis In A Chinese Population Sample

Differential serum lipid distribution in IPAH and CHD-PAH patients

Association Between Plasma Lysophosphatidic Acid and Coronary Stenosis with Coronary Heart Disease

Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)

Serum HMGB1 Levels and Its Clinical Significance in Patients with Idiopathic Pulmonary Arterial Hypertension

Plasma Levels of High Density Lipoprotein Cholesterol and Outcomes in Chronic Thromboembolic Pulmonary Hypertension.

SERUM HUMAN EPIDIDYMIS PROTEIN 4 LEVELS PREDICT CLINICAL WORSENING IN PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

Increased serum PCSK9 in patients with idiopathic pulmonary arterial hypertension: insights from inflammatory cytokines

The Correlation between Serum Phospholipid Fatty Acids and Blood Lipids in Hypertension

Serum high mobility group box 1 levels and its clinical significance in patients with pulmonary arterial hypertension associated with congenital heart disease.

Clinical Analysis of 150 Patients with Idiopathic Pulmonary Arterial Hypertension

The Prognostic Impact of Serum Uric Acid on Disease Severity and 5-Year Mortality in Patients With Idiopathic Pulmonary Artery Hypertension

Study of hypo-high-density-lipoproteinemia and coronary artery lesions in patients with coronary heart disease

The effect of docosahexaenoic acid on predicting the survival of patients with idiopathic pulmonary arterial hypertension

Cardiopulmonary Exercise Testing Combined with Haemodynamics for the Prediction of Outcome in Idiopathic Pulmonary Arterial Hypertension

Expression and Significance of Serum Cyclophilin A and Melatonin in Patients with Hypertension and Left Ventricular Hypertrophy

The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension

Prognostic Value of Follicle-Stimulating Hormone Levels in Predicting Survival in Men with Idiopathic Pulmonary Arterial Hypertension

Decreased Low-Density Lipoprotein and the Presence of Pulmonary Arterial Hypertension among Newly Diagnosed Drug-Naïve Patients with Systemic Lupus Erythematosus: D-dimer As a Mediator.